Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Aragon Pharmaceuticals, Inc. · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
prostate-cancer
prostate cancer, men with biochemically relapsed hormone sensitive prostate cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 862884
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.